Study to Evaluate the Use of Surgical Gloves for the Prevention of Oxaliplatin-Induced Peripheral Neuropathy
Recruiting · NCT07285356 · Interventional (participants receive a specific treatment) · Lead sponsor: AC Camargo Cancer Center
View the official record on ClinicalTrials.gov →Interventions studied
Surgical Gloves
What this trial is about
The primary objective of this randomized clinical trial is to assess whether the use of surgical gloves during treatment can prevent the occurrence of oxaliplatin-induced peripheral neuropathy.
Who can take part
Age range
18 Years and older
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not applicable (e.g. observational or device study)
Study type
Interventional (participants receive a specific treatment)
Inclusion criteria
- Patients aged 18 years or older who have provided written informed consent.
- Colon adenocarcinoma with high-risk stage III (pT4pN2) or stage IV.
- Oxaliplatin-based treatment in the context of localized or metastatic disease.
- Eastern Cooperative Oncology Group (ECOG) performance status of 0-1.
Exclusion criteria
- Pre-existing neuropathy.
- Uncontrolled diabetes.
- known glove allergies.
- Prior treatment with paclitaxel, docetaxel or oxaliplatin.
Where it is running
1 location listed.
- A.C. Camargo Cancer Center - São Paulo, São Paulo, Brazil